{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Single+intravenous+doses+of+placebo", "query": { "intervention": "Single intravenous doses of placebo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 676, "total_pages": 68, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Single+intravenous+doses+of+placebo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-05T14:06:02.465Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02848729", "title": "Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Oral Acetaminophen", "type": "DRUG" }, { "name": "IV Acetaminophen", "type": "DRUG" }, { "name": "IV Morphine", "type": "DRUG" }, { "name": "Placebo Tablets", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 50, "start_date": "2016-02", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 3, "location_summary": "Tucson, Arizona • Naples, Florida • Kingston, Rhode Island", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Naples", "state": "Florida" }, { "city": "Kingston", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT02848729" }, { "nct_id": "NCT04766931", "title": "The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "FB2001", "type": "DRUG" }, { "name": "FB2001 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Frontier Biotechnologies Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 88, "start_date": "2021-03-17", "completion_date": "2022-08-12", "has_results": false, "last_update_posted_date": "2022-11-28", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 1, "location_summary": "Secaucus, New Jersey", "locations": [ { "city": "Secaucus", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04766931" }, { "nct_id": "NCT00051636", "title": "Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Paget's Disease of Bone" ], "interventions": [ { "name": "Zoledronic Acid", "type": "DRUG" }, { "name": "Risedronate", "type": "DRUG" }, { "name": "Placebo to Risedronate", "type": "DRUG" }, { "name": "Placebo to Zoledronic Acid", "type": "DRUG" }, { "name": "Calcium and Vitamin D", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 172, "start_date": "2001-01", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-05-15", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 12, "location_summary": "Santa Monica, California • Lakewood, Colorado • Boca Raton, Florida + 9 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00051636" }, { "nct_id": "NCT01934361", "title": "Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Glioblastoma Multiforme" ], "interventions": [ { "name": "buparlisib", "type": "DRUG" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "lomustine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2014-02-28", "completion_date": "2016-07-07", "has_results": false, "last_update_posted_date": "2020-12-09", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Fayetteville, Arkansas • Chicago, Illinois + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01934361" }, { "nct_id": "NCT04583956", "title": "ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Remdesivir", "type": "DRUG" }, { "name": "Risankizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 214, "start_date": "2020-10-23", "completion_date": "2021-09-13", "has_results": true, "last_update_posted_date": "2023-05-16", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 32, "location_summary": "Tucson, Arizona • Bakersfield, California • Newport Beach, California + 26 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04583956" }, { "nct_id": "NCT00991159", "title": "A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "RN316", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 48, "start_date": "2009-11", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2012-07-04", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 2, "location_summary": "Phoenix, Arizona • Miami Gardens, Florida", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Miami Gardens", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00991159" }, { "nct_id": "NCT01651351", "title": "GLASSIA Infusion Rate Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alpha1-antitrypsin Deficiency", "Healthy Volunteers" ], "interventions": [ { "name": "Alpha1-proteinase inhibitor", "type": "BIOLOGICAL" }, { "name": "Placebo: Human albumin 2.5%", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2012-07-31", "completion_date": "2013-01-16", "has_results": true, "last_update_posted_date": "2021-05-25", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01651351" }, { "nct_id": "NCT03139279", "title": "Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Colonoscopy" ], "interventions": [ { "name": "Dexmedetomidine", "type": "DRUG" }, { "name": "Saline placebo", "type": "OTHER" }, { "name": "Propofol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "State University of New York - Downstate Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 122, "start_date": "2017-05-05", "completion_date": "2018-07-19", "has_results": true, "last_update_posted_date": "2019-07-29", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 1, "location_summary": "Brooklyn, New York", "locations": [ { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03139279" }, { "nct_id": "NCT01892189", "title": "Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ketamine-Induced Brain Activity Changes", "Psychotic-like Symptoms" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "TAK-063", "type": "DRUG" }, { "name": "TAK-063 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 27, "start_date": "2013-08", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01892189" }, { "nct_id": "NCT00103740", "title": "Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Paget's Disease of Bone" ], "interventions": [ { "name": "zoledronic acid", "type": "DRUG" }, { "name": "placebo to zoledronic acid", "type": "DRUG" }, { "name": "Risedronate", "type": "DRUG" }, { "name": "Placebo to risedronate", "type": "DRUG" }, { "name": "Calcium and vitamin D supplements", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 185, "start_date": "2002-04", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-06-04", "last_synced_at": "2026-10-05T14:06:02.465Z", "location_count": 10, "location_summary": "Tucson, Arizona • Colorado Springs, Colorado • Indianapolis, Indiana + 7 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00103740" } ] }